Related Experiment Videos

Mdm2: keeping p53 under control

J Piette1, H Neel, V Maréchal

  • 1Institut de Génétique Moléculaire de Montpellier, CNRS-BP5051, France.

Oncogene
|August 28, 1997
PubMed

Insights

The Mdm2 protein inhibits the tumor suppressor p53, leading to cancer. Mdm2 targets p53 for degradation and also has p53-independent functions.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The Mdm2 gene is frequently overexpressed in various human cancers.
  • Mdm2's oncogenic activity is partly due to its inhibition of the tumor suppressor protein p53.
  • Mdm2 plays a crucial role in regulating p53 activity, particularly during early development.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which Mdm2 inhibits p53.
  • To understand the structural basis of Mdm2-p53 interaction.
  • To explore the p53-independent functions of Mdm2.

Main Methods:

  • Three-dimensional structural determination of Mdm2-p53 N-terminal peptide complexes.
  • Analysis of Mdm2-mediated degradation of p53.
  • Investigation of the feedback loop between p53 and Mdm2 gene expression.

Main Results:

  • Structural data revealed the molecular basis for Mdm2's inhibition of p53's transcriptional activity.
  • Mdm2 was shown to target p53 for rapid degradation.
  • Evidence for p53-independent functions of Mdm2 was presented.

Conclusions:

  • Mdm2's interaction with p53 is critical for controlling p53's tumor-suppressive functions.
  • Mdm2-mediated degradation is a key mechanism for p53 regulation.
  • Mdm2 possesses functions beyond its interaction with p53, suggesting broader roles in cellular processes.

Related Concept Videos